Induction Treatment of Acute Myeloid Leukemia in an Elderly Patient With Intra-marrow Injection of Cytarabine (Ara-C)

被引：0
|
作者：
Islam, Anwarul [1 ]
机构：
[1] Buffalo Gen Med Ctr, Buffalo, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; elderly; treatment; intra-marrow injection; case;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-097
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 50 条
  • [21] CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML) REFRACTORY TO ANTHRACYCLINE CYTARABINE (ARA-C) THERAPIES
    KALWINSKY, D
    LOOK, AT
    MIRRO, J
    DAHL, GV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 193 - 193
  • [22] ARA-C, IDARUBICINE AND GEMTUZUMAB OZOGAMICIN AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
    Capria, S.
    Cardarelli, L.
    Trisolini, S. M.
    Cartoni, C.
    Minotti, C.
    Gianfelici, V
    Arleo, E.
    Santini, L.
    De Propris, M. S.
    Mancini, M.
    Martinelli, G.
    Foa, R.
    Meloni, G.
    HAEMATOLOGICA, 2008, 93 : S84 - S84
  • [23] HIGH-DOSE CYTARABINE (ARA-C) TREATMENT FOR THERAPY-RESISTENT ACUTE MYELOID-LEUKEMIA - EFFECT - SIDE-EFFECT
    MEUSERS, P
    MENKEN, U
    HEIDEMANN, H
    BRITTINGER, G
    ONKOLOGIE, 1983, 6 (05): : 224 - 224
  • [24] LOW-DOSE ARA-C(LODAC) IN ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    PETTI, MC
    AVVISATI, G
    SIKOGLOU, N
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [25] PHASE 1B RESULTS OF IDASANUTLIN plus CYTARABINE (ARA-C) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)
    Martinelli, G.
    Pappayannidis, C.
    Yee, K.
    Vey, N.
    Drummond, M.
    Kelly, K.
    Dickinson, M.
    Lee, J. H.
    Seiter, K.
    Yoon, S. S.
    Assouline, S.
    Kasner, M.
    Nichols, G.
    Middleton, S.
    Blotner, S.
    Zhi, J.
    Pierceall, W.
    Chen, L. C.
    HAEMATOLOGICA, 2016, 101 : 187 - 187
  • [26] PHASE 1B RESULTS OF IDASANUTLIN plus CYTARABINE (ARA-C) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)
    Martinelli, G.
    Papayannidis, C.
    Paolini, S.
    Yee, K.
    Vey, N.
    Drummond, M.
    Kelly, K.
    Dickinson, M.
    Lee, J. Hwan
    Seiter, K.
    Yoon, S. Soo
    Assouline, S.
    Kasner, M.
    Nichols, G.
    Middleton, S.
    Blotner, S.
    Zhi, J.
    Pierceall, W.
    Chen, L. C.
    HAEMATOLOGICA, 2017, 102 : 48 - 48
  • [27] ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (17) : 589 - 589
  • [28] Low dose cytarabine with or without anthracycline in the induction treatment of elderly patients with acute myeloid leukemia
    Abu-Taleb, F. M.
    Mansour, O. M.
    Khorshid, O. L. A. M. R.
    Raheem, A. Abdel
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S850 - S850
  • [29] Fludarabine, Ara-c and antracycline: A short, intensive and tolerable induction therapy of de novo acute myeloid leukemia
    Clavio, M
    Cerri, R
    Pierri, I
    Balleari, E
    Gatto, S
    Beltrami, G
    Masoudi, B
    Cavaliere, M
    Risso, M
    Pietrasanta, D
    Quintino, S
    Damasio, E
    Ghio, R
    Gobbi, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 220 - 221
  • [30] Treatment Acute Myeloid Leukemia Using Cytoreductive Chemotherapy Cytarabine (Ara-C) Followed Azacitidine (AZA)Maintenance: A Real Life Single Center Experience
    Greco, Rosa
    Petrungaro, Annamaria
    Recchia, Anna Grazia
    De Stefano, Laura
    Bossio, Sabrina
    Palummo, Angela
    Iaquinta, Giovanni
    Storino, Francesca
    Caruso, Nadia
    Gentile, Massimo
    Neri, Antonino
    Vigna, Ernesto
    Morabito, Fortunato
    BLOOD, 2016, 128 (22)
12345